DE68908445T2 - Mittel zur Behandlung von Lebererkrankungen. - Google Patents

Mittel zur Behandlung von Lebererkrankungen.

Info

Publication number
DE68908445T2
DE68908445T2 DE89302629T DE68908445T DE68908445T2 DE 68908445 T2 DE68908445 T2 DE 68908445T2 DE 89302629 T DE89302629 T DE 89302629T DE 68908445 T DE68908445 T DE 68908445T DE 68908445 T2 DE68908445 T2 DE 68908445T2
Authority
DE
Germany
Prior art keywords
agents
treatment
liver diseases
liver
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE89302629T
Other languages
English (en)
Other versions
DE68908445D1 (de
Inventor
Dai Nakae
Yoichi Konishi
Yoshihiko Nagata
Youshiro Kobayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Tosoh Corp
Asahi Chemical Industry Co Ltd
Original Assignee
Tosoh Corp
Asahi Chemical Industry Co Ltd
Asahi Kasei Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tosoh Corp, Asahi Chemical Industry Co Ltd, Asahi Kasei Kogyo KK filed Critical Tosoh Corp
Publication of DE68908445D1 publication Critical patent/DE68908445D1/de
Application granted granted Critical
Publication of DE68908445T2 publication Critical patent/DE68908445T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
DE89302629T 1988-03-18 1989-03-17 Mittel zur Behandlung von Lebererkrankungen. Expired - Fee Related DE68908445T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63065337A JPH01238537A (ja) 1988-03-18 1988-03-18 肝障害治療剤

Publications (2)

Publication Number Publication Date
DE68908445D1 DE68908445D1 (de) 1993-09-23
DE68908445T2 true DE68908445T2 (de) 1994-04-21

Family

ID=13284016

Family Applications (1)

Application Number Title Priority Date Filing Date
DE89302629T Expired - Fee Related DE68908445T2 (de) 1988-03-18 1989-03-17 Mittel zur Behandlung von Lebererkrankungen.

Country Status (3)

Country Link
EP (1) EP0333490B1 (de)
JP (1) JPH01238537A (de)
DE (1) DE68908445T2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR940000166B1 (ko) * 1989-11-09 1994-01-08 니혼다바고 상교오 가부시기가이샤 신규 글루코사민 유도체 및 이것을 막 구성성분으로서 함유한 리포솜
US5278300A (en) * 1990-04-12 1994-01-11 Japan Tobacco, Inc. 4,6-o-hydroxyphosphoryl-glucosamine derivatives
FR2806911B1 (fr) * 2000-03-28 2003-01-10 Univ Rene Descartes Utilisation de mimetiques de la sod dans le traitement d'insuffisances hepatocellulaires
UA97559C2 (uk) 2007-11-08 2012-02-27 Оцука Фармасьютікал Ко., Лтд. Комплекс нуклеїнової кислоти і композиція для доставки нуклеїнової кислоти

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024247A (en) * 1971-12-27 1977-05-17 Palolab Pharmaceuticals Corporation Composition and method of using a protein mixture derived from liver
DK402785D0 (da) * 1985-09-03 1985-09-03 Syn Tek Ab Fremgangsmaade til fremstilling af et enzym
EP0225130B1 (de) * 1985-11-22 1991-10-30 Takeda Chemical Industries, Ltd. Liposomzusammensetzung
JPH0751496B2 (ja) * 1986-04-02 1995-06-05 武田薬品工業株式会社 リポソ−ムの製造法

Also Published As

Publication number Publication date
DE68908445D1 (de) 1993-09-23
JPH01238537A (ja) 1989-09-22
EP0333490A3 (en) 1989-11-02
EP0333490A2 (de) 1989-09-20
EP0333490B1 (de) 1993-08-18

Similar Documents

Publication Publication Date Title
DE68907909T2 (de) Präparat zur behandlung von erektionsstörungen.
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE3772429D1 (de) Pharmazeutisches praeparat zur behandlung von peridontalkrankheiten.
DE69019488D1 (de) Behandlung von Geflügel.
DE3882775T2 (de) Zusammensetzung zur Behandlung von parodontaler Krankheit.
DE3685633D1 (de) Behandlung von knochenstoerungen.
DE69018043D1 (de) Behandlung von Geflügel.
DE3782214D1 (de) Mittel zur behandlung des scheidenmilieus.
DE58906239D1 (de) Einrichtung zur Behandlung von Erkrankungen, insbesondere der Sehbahn.
DE3687097D1 (de) Therapeutisches mittel zur behandlung haematopoietischer krankheiten.
DE68911776T2 (de) Konjugierte Oxybutenolide zur Behandlung von Ulcera.
DE68923219T2 (de) Behandlung von Abfällen.
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
DE68908445T2 (de) Mittel zur Behandlung von Lebererkrankungen.
DE69408394T2 (de) 4-Piperidino-piperidin zur Behandlung von Tumoren
DE68907569T2 (de) Mittel zur Behandlung oder Vorbeugung von Aids.
DE69813354D1 (de) Mittel zur Behandlung von Herzkrankheiten
LU84488A1 (de) Mittel zur behandlung von akne
DE3668116D1 (de) Zusammensetzung zur behandlung von infektionen.
DE68918449D1 (de) Siliziumverbindungen zur behandlung von knochen.
DE68914886T2 (de) Mittel zur Behandlung von Raynaud's Krankheit.
DE3877199T3 (de) Verfahren zur Behandlung der Kopfhaut.
ATE91886T1 (de) Praeparat zur behandlung von erektionsstoerungen.
ATE86857T1 (de) Transdermate magensafthemmende wirkstoffe zur behandlung von magen-darm-erkrankungen.
ATE63457T1 (de) Arzneimittel zur behandlung und prophylaxe von leber- und nierenkrankheiten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee